Corient Capital Partners’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $1.07M | Buy |
11,263
+414
| +4% | +$39.4K | 0.08% | 211 |
|
|
2022
Q2 | $1.03M | Buy |
10,849
+1,000
| +10% | +$95.1K | 0.08% | 224 |
|
|
2022
Q1 | $1.16M | Buy |
9,849
+657
| +7% | +$77.3K | 0.08% | 225 |
|
|
2021
Q4 | $1.19M | Sell |
9,192
-7,736
| -46% | -$1M | 0.08% | 209 |
|
|
2021
Q3 | $1.92M | Sell |
16,928
-1,925
| -10% | -$218K | 0.14% | 143 |
|
|
2021
Q2 | $1.95M | Buy |
18,853
+3,367
| +22% | +$349K | 0.14% | 137 |
|
|
2021
Q1 | $1.3M | Buy |
15,486
+8,463
| +121% | +$708K | 0.11% | 169 |
|
|
2020
Q4 | $641K | Buy |
7,023
+218
| +3% | +$19.9K | 0.06% | 240 |
|
|
2020
Q3 | $543K | Sell |
6,805
-158
| -2% | -$12.6K | 0.06% | 246 |
|
|
2020
Q2 | $481K | Buy |
6,963
+672
| +11% | +$46.4K | 0.06% | 253 |
|
|
2020
Q1 | $395K | Sell |
6,291
-759
| -11% | -$47.7K | 0.06% | 256 |
|
|
2019
Q4 | $549K | Buy |
7,050
+327
| +5% | +$25.5K | 0.07% | 269 |
|
|
2019
Q3 | $492K | Buy |
6,723
+1,575
| +31% | +$115K | 0.07% | 265 |
|
|
2019
Q2 | $317K | Buy |
5,148
+354
| +7% | +$21.8K | 0.05% | 296 |
|
|
2019
Q1 | $306K | Buy |
+4,794
| New | +$306K | 0.05% | 278 |
|